Nottingham University Hospitals NHS Trust
nuh.nhs.ukLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
105
Active
15
Phase 3
3
Total enrollment
139,199
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Bacillus Calmette-Guerin Vaccine Intravesical | — | — | — | — | — | 1 | |
| Mitomycin | — | — | — | — | — | 1 | |
| Blood sample provided | — | — | — | — | — | 1 |
Next readouts
- 2026-07-31
- 2026-12-01
Top conditions
- Cystic Fibrosis6
- Multiple Sclerosis5
- Covid194
- Anesthesia4
- Anemia3
- Hearing Loss3
- Constipation2
- Asthma2
Frequently asked questions about Nottingham University Hospitals NHS Trust
- How many clinical trials does Nottingham University Hospitals NHS Trust have on ClinicalTrials.gov?
- Nottingham University Hospitals NHS Trust is listed as the lead sponsor on 105 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Nottingham University Hospitals NHS Trust's trials are in Phase 3?
- 3 of Nottingham University Hospitals NHS Trust's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Nottingham University Hospitals NHS Trust focus on?
- Nottingham University Hospitals NHS Trust's most-studied conditions on ClinicalTrials.gov are Cystic Fibrosis, Multiple Sclerosis, Covid19, Anesthesia, Anemia.
- When are Nottingham University Hospitals NHS Trust's next clinical trial readouts?
- Nottingham University Hospitals NHS Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “Longitudinal Assessment of Iron Rims in MS Lesions”, expected around 2026-07-31.